Dublin, June 12, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/94...mmunoassay ) has announced the addition of the "Immunoassay Market by Technology, Application, & End User - Global Forecast to 2019" report to their offering. The immunoassay market is expected to reach $23,712.4 Million by 2019 from $14,926.3 Million in 2014, at a CAGR of 9.7% from 2014 to 2019
The immunoassay market is segmented on the basis of technology, products and services, applications, end users and regions. On the basis of products and services, the global immunoassay market is segmented into analyzers, reagents and kits, and software and services. The immunoassay analyzers market is further segmented based on into purchase mode reagent rental purchase and outright purchase and by type open-ended system and closed-ended system. The immunoassay reagents and kits market segment is classified into ELISA reagents, rapid tests reagents, western blot reagents, ELISPOT reagent, radioimmunoassay (RIA) reagents and PCR reagents. Based on technologies, the global immunoassay market is segmented into ELISA, rapid tests, western blot tests, enzyme-linked immunospot (ELISPOT) assay, radioimmunoassays (RIA), and PCR. The immunoassay market for ELISA testing is further categorized into first-generation, second-generation, third-generation, and fourth-generation ELISA. Based on end users, the immunoassay market is segmented into hospitals, laboratories, blood banks, academic research centers, pharmaceutical companies, CROs, and biotechnology companies, and others (physicians' offices, patient self-testing, and ambulatory centers). The global immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global immunoassay market in the forecast period. Over the next five years, the growth of the market in the Asian region is likely to be centered on China, India, and Japan. The key players in the immunoassay market include Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho Clinical Diagnostics (U.S.), and bioMérieux (France). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Immunoassay Market, By Technology 8 Immunoassay Market, By Products and Services 9 Immunoassay Market, By Application 10 Immunoassay Market, By End User 11 Immunoassay Market, By Region 12 Competitive Landscape 13 Company Profiles - Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton, Dickinson and Company - Bio-Rad Laboratories, Inc. - Biomérieux SA - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) - Siemens Healthcare (Subsidiary of Siemens AG) - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/94...mmunoassay
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology
